GO:1903860 negative regulation of dendrite extension: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903860 (negative regulation of dendrite extension) describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of dendrite extension.
• Key signaling pathways that negatively regulate dendrite extension include beta-catenin signaling, Cdk5-mediated regulation of Kalirin, CaMKI, and Robo2/Slit signaling [1,2,3,6].
• Dysregulation of dendrite extension is linked to neurodevelopmental disorders, neurodegeneration, and cancer [7,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal interrogation of genes that negatively regulate dendrite extension [1,2,6].
• Advanced methods such as live-cell imaging, RNA-seq, and proteomics are essential to dissect the molecular mechanisms of dendrite extension inhibition [2,4].
• EDITGENE provides comprehensive CRISPR services to study negative regulation of dendrite extension, from library screening to bioinformatics analysis.
Description
Dendrite extension is a fundamental process in neuronal development, determining the receptive field and connectivity of neurons. The Gene Ontology term GO:1903860, negative regulation of dendrite extension, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of dendrite extension. This regulation is critical for proper neural circuit formation and function, as unchecked dendrite growth can lead to aberrant connectivity and neurological disorders. Research has identified multiple signaling pathways that negatively regulate dendrite extension, including beta-catenin signaling, which inhibits retinal-neurite extension, and Cdk5-mediated phosphorylation of Kalirin, which affects dendritic spine morphogenesis. Understanding these mechanisms is essential for uncovering the molecular basis of neurodevelopmental and neurodegenerative diseases. Moreover, the negative regulation of dendrite extension is not limited to neurons; similar processes can influence cancer cell morphology and metastasis. This article synthesizes current knowledge on GO:1903860, highlighting key genes, regulatory mechanisms, and experimental approaches, including CRISPR-based models, to study this process.
negative regulation of dendrite extension At A Glance
| GO ID | GO:1903860 |
|---|---|
| GO term | negative regulation of dendrite extension |
| Ontology | biological_process |
| Synonym | down regulation of dendrite extension, down-regulation of dendrite extension, downregulation of dendrite extension, inhibition of dendrite extension, up regulation of dendrite retraction, up-regulation of dendrite retraction |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of dendrite extension |
| Related processes | Dendrite morphogenesis, neurite outgrowth, axon guidance |
| Key regulators | Beta-catenin, Cdk5, Kalirin, CaMKI, Robo2, Nurr1, MDGA1, Pip5k1γ |
| Disease relevance | Neurodevelopmental disorders, neurodegeneration, cancer |
What Is GO:1903860?
GO:1903860, negative regulation of dendrite extension, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of dendrite extension. This biological process ensures that dendrites do not overgrow, maintaining proper neuronal morphology and connectivity. It involves a variety of molecular signals that converge on the cytoskeleton and membrane trafficking machinery to halt dendrite outgrowth.
Why Is negative regulation of dendrite extension Important in Cell Biology?
The negative regulation of dendrite extension is crucial for proper nervous system development and function. Without tight control, neurons may form excessive or aberrant dendritic arbors, leading to disrupted synaptic connectivity and neurological disorders. For instance, beta-catenin signaling negatively regulates retinal neurite extension, and its dysregulation can contribute to retinal pathologies. Similarly, Cdk5-mediated regulation of Kalirin is essential for dendritic spine morphogenesis, and its perturbation is linked to neurodegenerative diseases. Understanding these regulatory mechanisms provides insights into the etiology of neurodevelopmental disorders such as autism and schizophrenia, as well as potential therapeutic targets for promoting or inhibiting dendrite growth in disease contexts.
• Critical for proper neural circuit formation and synaptic connectivity.
• Dysregulation leads to neurodevelopmental disorders, including autism spectrum disorders.
• Implicated in neurodegenerative diseases such as Alzheimer's disease through proteins like MDGA1.
• Plays a role in cancer cell morphology and metastasis, as seen with beta-catenin signaling.
• Provides targets for therapeutic intervention in retinal degeneration.
• Essential for understanding neuronal polarity and axon-dendrite specification.
• Involved in activity-dependent plasticity and cognitive function.
• Key to deciphering molecular mechanisms of cytoskeletal dynamics.
• Relevant for regenerative medicine and neural repair strategies.
• Offers insights into the role of lipid signaling in neurite growth.
What Happens During negative regulation of dendrite extension?
Initiation of inhibitory signaling
In simple terms: A signal tells the neuron to stop growing dendrites.
Negative regulation of dendrite extension begins with extracellular or intracellular cues that activate inhibitory signaling pathways. For example, beta-catenin signaling can be activated by Wnt ligands, leading to inhibition of retinal neurite extension. Similarly, Cdk5 phosphorylates Kalirin, modulating its activity to restrict dendritic growth. These initial signals set off a cascade that ultimately halts dendrite extension.
Cytoskeletal reorganization
In simple terms: The cell's internal skeleton is rearranged to stop growth.
Upon inhibitory signaling, the cytoskeleton undergoes reorganization. CaMKI regulates growth cone motility and axonal extension, and its inhibition can lead to reduced neurite outgrowth. Pip5k1γ regulates axon formation by limiting Rap1 activity, affecting cytoskeletal dynamics. These changes in actin and microtubule networks prevent further extension of dendrites.
Membrane trafficking and retraction
In simple terms: The cell membrane is pulled back to shorten the dendrite.
Negative regulation also involves membrane trafficking events that lead to dendrite retraction. Robo2 signaling regulates axon and dendrite growth by retinal ganglion cells, and its activation can cause growth cone collapse. Nurr1 down-regulation affects neurite extension in dopaminergic cells, possibly through altered gene expression. These processes culminate in the physical retraction of dendrites.
Transcriptional and translational control
In simple terms: The cell changes which proteins it makes to stop dendrite growth.
Long-term negative regulation often requires changes in gene expression. Beta-catenin accumulation in neuroblastoma cells inhibits proliferation and induces neurite extension via up-regulation of trkA, indicating a complex role in neurite outgrowth. MDGA1 negatively regulates amyloid precursor protein-mediated synapse inhibition, influencing synaptic and dendritic morphology. These transcriptional and translational changes reinforce the inhibition of dendrite extension.
Key Genes Involved in GO:1903860 negative regulation of dendrite extension
The following genes and proteins have been experimentally implicated in the negative regulation of dendrite extension, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CTNNB1 (beta-catenin) | Negatively regulates retinal neurite extension | Involved in Wnt signaling; dysregulated in cancer and neurodegeneration [1,8] |
| CDK5 | Phosphorylates Kalirin to regulate dendritic spine morphogenesis | Linked to neurodegenerative diseases; target for neuroprotection |
| KALRN (Kalirin) | Regulates dendritic spine morphogenesis | Implicated in schizophrenia and cognitive disorders |
| CAMK1 | Regulates axonal extension and growth cone motility | Role in neuronal development and plasticity |
| PIP5K1C (Pip5k1γ) | Regulates axon formation by limiting Rap1 activity | Involved in neuronal polarity and lipid signaling |
| NR4A2 (Nurr1) | Down-regulation affects neurite extension in dopaminergic cells | Linked to Parkinson's disease |
| ROBO2 | Regulates axon and dendrite growth by retinal ganglion cells | Axon guidance molecule; role in neurodevelopmental disorders |
| MDGA1 | Negatively regulates amyloid precursor protein-mediated synapse inhibition | Implicated in Alzheimer's disease and synaptic function |
| NTRK1 (trkA) | Up-regulated by beta-catenin to induce neurite extension | Neurotrophin receptor; involved in neuroblastoma differentiation |
| RAP1 | Inhibited by Pip5k1γ to limit axon formation | Small GTPase; regulates cytoskeletal dynamics |
| APP | Amyloid precursor protein; its mediated synapse inhibition is regulated by MDGA1 | Central to Alzheimer's disease pathogenesis |
| TH | Tyrosine hydroxylase; expression affected by Nurr1 down-regulation | Dopamine synthesis; Parkinson's disease marker |
| WNT | Ligands that activate beta-catenin signaling | Morphogens in neural development |
| SLIT | Ligand for Robo2 | Axon guidance cue |
| GSK3B | Regulates beta-catenin stability | Kinase involved in multiple signaling pathways |
| CREB | Transcription factor downstream of CaMKI | Regulates gene expression in neurons |
| RAC1 | Small GTPase regulated by Kalirin | Cytoskeletal dynamics |
How Is negative regulation of dendrite extension Regulated?
The negative regulation of dendrite extension is itself subject to multiple layers of regulation. Beta-catenin signaling is modulated by GSK3B and Wnt ligands. Cdk5 activity is regulated by its activator p35/p39 and by phosphorylation. CaMKI is activated by calcium/calmodulin and can be modulated by upstream kinases. Pip5k1γ activity is controlled by its lipid substrates and interacting proteins. Additionally, Robo2 signaling is regulated by Slit ligands and by receptor trafficking. These regulatory mechanisms ensure precise control of dendrite extension in response to developmental and environmental cues.
negative regulation of dendrite extension and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTNNB1 | Cancer, retinal degeneration | Knockout or overexpression in retinal neurons or cancer cell lines [1,8] |
| CDK5 | Neurodegeneration, schizophrenia | Point mutation or knockout in primary neurons |
| ROBO2 | Neurodevelopmental disorders | Knockout or knock-in in retinal ganglion cells |
| NR4A2 | Parkinson's disease | Knockdown or knockout in dopaminergic neurons |
| MDGA1 | Alzheimer's disease | Overexpression or knockout in hippocampal neurons |
Neurodevelopmental disorders
Disruption of negative regulation of dendrite extension can lead to neurodevelopmental disorders such as autism spectrum disorders and intellectual disability. For example, mutations in ROBO2 have been associated with neurodevelopmental phenotypes. Similarly, dysregulation of Kalirin, a target of Cdk5, has been implicated in schizophrenia. Proper control of dendrite extension is essential for establishing correct neural circuits, and its perturbation may contribute to these disorders.
Neurodegenerative diseases
In neurodegenerative diseases like Alzheimer's disease, proteins such as MDGA1 and APP play roles in synapse inhibition and dendritic morphology. Beta-catenin signaling, which negatively regulates neurite extension, is also altered in Alzheimer's disease. Nurr1 down-regulation affects dopaminergic neurite extension and is linked to Parkinson's disease. These findings suggest that targeting negative regulation of dendrite extension could offer therapeutic avenues for neurodegeneration.
Cancer
Beta-catenin signaling is a well-known oncogenic pathway, and its role in negatively regulating neurite extension may have implications for cancer cell invasion and metastasis. In neuroblastoma, artificially accumulated beta-catenin inhibits proliferation and induces neurite extension via up-regulation of trkA, highlighting a complex interplay between differentiation and growth. Understanding how negative regulation of dendrite extension intersects with cancer biology could reveal new targets for therapy.
From negative regulation of dendrite extension-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate dendrite extension? | CRISPR knockout in primary neurons or cell lines [1,2] |
| What is the effect of a specific point mutation in gene X on dendrite extension? | CRISPR point mutation knock-in |
| How does tagging gene X affect its localization and function? | CRISPR knock-in of fluorescent tag |
| Does overexpression of gene X inhibit dendrite extension? | CRISPR overexpression (e.g., CRISPRa) |
| What are the downstream targets of gene X in dendrite extension? | CRISPR library screening combined with RNA-seq [3,6] |
| Can we rescue the phenotype by re-expressing wild-type gene X? | Knock-in of wild-type or mutant cDNA |
How to Study the negative regulation of dendrite extension Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Dendrite length and dynamics | Real-time observation of extension/retraction [1,6] |
| RNA-seq | Transcriptional changes | Identifying downstream targets [2,8] |
| Proteomics | Protein interactions and modifications | Mapping signaling networks [2,3] |
| Phosphoproteomics | Phosphorylation events | Kinase substrate identification [2,3] |
| CRISPR screening | Gene function on a genome-wide scale | Discovery of novel regulators [4,7] |
| Immunofluorescence | Protein localization and morphology | Validating candidate genes [5,6] |
| Western blot | Protein expression levels | Confirming knockout or overexpression [1,8] |
| qRT-PCR | mRNA expression levels | Validating transcriptional changes [5,8] |
Live-cell imaging
Live-cell imaging allows real-time visualization of dendrite extension and retraction in cultured neurons. By tagging cytoskeletal or membrane markers, researchers can quantify changes in dendrite length and dynamics upon genetic manipulation [1,6]. This method is essential for directly observing the effects of negative regulators.
RNA sequencing (RNA-seq)
RNA-seq can identify transcriptional changes associated with negative regulation of dendrite extension. For example, comparing wild-type and knockout neurons can reveal downstream targets of beta-catenin or Cdk5 signaling [2,8]. This approach provides a global view of gene expression programs.
Proteomics and phosphoproteomics
Proteomic analyses can uncover protein-protein interactions and post-translational modifications involved in dendrite extension inhibition. Phosphoproteomics is particularly useful for studying kinases like Cdk5 and CaMKI [2,3]. These methods help elucidate signaling cascades.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of dendrite extension. By coupling dendrite morphology readouts with pooled screens, researchers can discover genes that negatively regulate this process [4,7]. This unbiased approach accelerates gene discovery.
How CRISPR Can Be Used to Study GO:1903860 negative regulation of dendrite extension
Knockout
CRISPR knockout is used to completely abolish the function of a candidate gene to determine if it is necessary for negative regulation of dendrite extension. For example, knocking out CTNNB1 or CDK5 in neurons can lead to increased dendrite extension if these genes are negative regulators [1,2]. Knockout models are essential for loss-of-function studies.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific amino acid changes to study their effects on protein function. For instance, mutating phosphorylation sites in Kalirin can reveal how Cdk5-mediated phosphorylation regulates dendrite extension. This approach provides mechanistic insights into post-translational regulation.
Knock-in
CRISPR knock-in can be used to tag endogenous proteins with fluorescent markers or to introduce reporter genes. Tagging Pip5k1γ with GFP can reveal its localization during dendrite extension. Knock-in of disease-associated mutations can model human disorders in vitro or in vivo.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can drive high levels of a gene to test if it is sufficient to inhibit dendrite extension. Overexpressing beta-catenin in neuroblastoma cells induces neurite extension, highlighting context-dependent effects. Overexpression models complement loss-of-function studies.
How EDITGENE Supports negative regulation of dendrite extension Research
Researchers studying negative regulation of dendrite extension-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides a comprehensive suite of CRISPR services to facilitate these investigations, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of dendrite extension research.
Frequently Asked Questions About negative regulation of dendrite extension
What is GO:1903860?
GO:1903860 is the Gene Ontology term for negative regulation of dendrite extension, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of dendrite extension.
What genes are involved in negative regulation of dendrite extension?
Key genes include CTNNB1 (beta-catenin), CDK5, KALRN, CAMK1, PIP5K1C, NR4A2, ROBO2, and MDGA1, among others [1,2,3,4,5,6,7].
How does beta-catenin negatively regulate dendrite extension?
Beta-catenin signaling inhibits retinal neurite extension, and its accumulation can also induce neurite extension in neuroblastoma cells via up-regulation of trkA, indicating context-dependent roles [1,8].
What is the role of Cdk5 in dendrite extension?
Cdk5 phosphorylates Kalirin to regulate dendritic spine morphogenesis, thereby influencing dendrite extension.
Which diseases are associated with dysregulation of dendrite extension?
Neurodevelopmental disorders, neurodegenerative diseases like Alzheimer's and Parkinson's, and cancer have been linked to aberrant dendrite extension regulation [5,6,7,8].
How can CRISPR be used to study negative regulation of dendrite extension?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to manipulate candidate genes and observe effects on dendrite morphology [1,2,4,6].
What methods are used to measure dendrite extension?
Live-cell imaging, immunofluorescence, and morphological tracing are commonly used to quantify dendrite length and dynamics [1,6].
What is the role of Robo2 in dendrite extension?
Robo2 regulates axon and dendrite growth by retinal ganglion cells, acting as a negative regulator upon Slit binding.
How does Nurr1 affect neurite extension?
Down-regulation of Nurr1 affects the expression of tyrosine hydroxylase and neurite extension in dopaminergic cells.
What services does EDITGENE offer for studying dendrite extension?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study negative regulation of dendrite extension.
Conclusion
GO:1903860, negative regulation of dendrite extension, is a critical biological process that ensures proper neuronal morphology and connectivity. Through the action of key signaling pathways such as beta-catenin, Cdk5, and Robo2, neurons tightly control dendrite growth. Dysregulation of this process contributes to neurodevelopmental disorders, neurodegeneration, and cancer. Advances in CRISPR-based models and high-throughput methods are accelerating the discovery of novel regulators and mechanisms. EDITGENE's comprehensive services support researchers in dissecting these pathways, from gene knockout to library screening, facilitating breakthroughs in neurobiology and disease modeling.
References
- 1. Ouchi Y et al.. 2005. Negative regulation of retinal-neurite extension by beta-catenin signaling pathway.. J Cell Sci 118(Pt 19):4473-83 PMID: 16179606
- 2. Xin X et al.. 2008. Regulation of Kalirin by Cdk5.. J Cell Sci 121(Pt 15):2601-11 PMID: 18628310
- 3. Wayman GA et al.. 2004. Regulation of axonal extension and growth cone motility by calmodulin-dependent protein kinase I.. J Neurosci 24(15):3786-94 PMID: 15084659
- 4. Di Meo D et al.. 2024. Pip5k1γ regulates axon formation by limiting Rap1 activity.. Life Sci Alliance 7(5) PMID: 38438249
- 5. Wu YC et al.. 2006. [Effects of Nurr1 down-regulation on the expression of tyrosine hydroxylase and neurite extension in dopaminergic cells.].. Sheng Li Xue Bao 58(4):351-8 PMID: 16906336
- 6. Hocking JC et al.. 2010. Distinct roles for Robo2 in the regulation of axon and dendrite growth by retinal ganglion cells.. Mech Dev 127(1-2):36-48 PMID: 19961927
- 7. Kim J et al.. 2022. MDGA1 negatively regulates amyloid precursor protein-mediated synapse inhibition in the hippocampus.. Proc Natl Acad Sci U S A 119(4) PMID: 35074912
- 8. Sangkhathat S et al.. 2006. Artificially accumulated beta-catenin inhibits proliferation and induces neurite extension of neuroblastoma cell line NB-1 via up-regulation of trkA.. Oncol Rep 16(6):1197-203 PMID: 17089037
